A citation-based method for searching scientific literature

J Mazieres, C Cropet, L Montané, F Barlesi, P J Souquet, X Quantin, C Dubos-Arvis, J Otto, L Favier, V Avrillon, J Cadranel, D Moro-Sibilot, I Monnet, V Westeel, J Le Treut, E Brain, J Trédaniel, M Jaffro, S Collot, G R Ferretti, C Tiffon, C Mahier-Ait Oukhatar, J Y Blay. Ann Oncol 2020
Times Cited: 59



Antonio Marchetti, Lara Felicioni, Sara Malatesta, Maria Grazia Sciarrotta, Luigi Guetti, Antonio Chella, Patrizia Viola, Carmela Pullara, Felice Mucilli, Fiamma Buttitta. J Clin Oncol 2011
Times Cited: 358




List of shared articles



Times cited

BRAF: A Two-Faced Janus.
Pasquale Pisapia, Francesco Pepe, Antonino Iaccarino, Roberta Sgariglia, Mariantonia Nacchio, Gianluca Russo, Gianluca Gragnano, Umberto Malapelle, Giancarlo Troncone. Cells 2020
10


Recent advances in lung cancer genomics: Application in targeted therapy.
Neha Pathak, Sindhura Chitikela, Prabhat Singh Malik. Adv Genet 2021
1

Immune biomarkers and response to checkpoint inhibition of BRAFV600 and BRAF non-V600 altered lung cancers.
Yonina R Murciano-Goroff, Terry Pak, Sebastian Mondaca, Jessica R Flynn, Joseph Montecalvo, Natasha Rekhtman, Darragh Halpenny, Andrew J Plodkowski, Stephanie L Wu, Mark G Kris,[...]. Br J Cancer 2022
2

Expression and Prognostic Significance of c-Myc, ALK, ROS1, BRAF, and PD-L1 Among Patients With Non-Small Cell Lung Cancer.
Patrapim Sunpaweravong, Patcharaporn Thongwatchara, Rassamee Chotipanvithayakul, Surasak Sangkhathat, Paramee Thongsuksai. Clin Med Insights Oncol 2022
0

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective.
Ningning Yan, Sanxing Guo, Huixian Zhang, Ziheng Zhang, Shujing Shen, Xingya Li. Front Oncol 2022
3

How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC).
Fabrizio Tabbò, Chiara Pisano, Julien Mazieres, Laura Mezquita, Ernest Nadal, David Planchard, Anne Pradines, David Santamaria, Aurélie Swalduz, Chiara Ambrogio,[...]. Cancer Treat Rev 2022
1

Clinical Outcomes With Dabrafenib Plus Trametinib in a Clinical Trial Versus Real-World Standard of Care in Patients With BRAF-Mutated Advanced NSCLC.
Bruce E Johnson, Christina S Baik, Julien Mazieres, Harry J M Groen, Barbara Melosky, Jürgen Wolf, Fatemeh Asad Zadeh Vosta Kolaei, Wen-Hsing Wu, Stefanie Knoll, Meryem Ktiouet Dawson,[...]. JTO Clin Res Rep 2022
0

Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions.
Mariona Riudavets, Priscilla Cascetta, David Planchard. Lung Cancer 2022
0

BRAF as a positive predictive biomarker: Focus on lung cancer and melanoma patients.
Umberto Malapelle, Giulio Rossi, Pasquale Pisapia, Massimo Barberis, Fiamma Buttitta, Francesca Castiglione, Fabiana Letizia Cecere, Antonio Maria Grimaldi, Antonino Iaccarino, Antonio Marchetti,[...]. Crit Rev Oncol Hematol 2020
9

Targeted Therapy in BRAF p.K601E-Driven NSCLC: Case Report and Literature Review.
Felix C Saalfeld, Carina Wenzel, Daniela E Aust, Martin Wermke. JCO Precis Oncol 2020
2

BRAFV600E-Driven Lung Adenocarcinoma Requires Copper to Sustain Autophagic Signaling and Processing.
Tiffany Tsang, Xingxing Gu, Caroline I Davis, Jessica M Posimo, Zoey A Miller, Donita C Brady. Mol Cancer Res 2022
0

Clinicopathological aspects of V-Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutated non-small cell lung carcinoma in an Indian cohort: is there a difference?
Ullas Batra, Shrinidhi Nathany, Mansi Sharma, Sakshi Mattoo, Anurag Mehta, Joslia T Jose. Int J Mol Epidemiol Genet 2021
0

Uncommon targets in non-small cell lung cancer: Everyone wants a slice of cake.
Alessandro De Toma, Giuseppe Lo Russo, Diego Signorelli, Filippo Pagani, Giovanni Randon, Giulia Galli, Arsela Prelaj, Roberto Ferrara, Claudia Proto, Monica Ganzinelli,[...]. Crit Rev Oncol Hematol 2021
3


A BRAF new world.
Daniele Frisone, Alex Friedlaender, Umberto Malapelle, Giuseppe Banna, Alfredo Addeo. Crit Rev Oncol Hematol 2020
23

Targeting molecular alterations in non-small-cell lung cancer: what's next?
Rafael López-Castro, Tania García-Peña, Xabier Mielgo-Rubio, Mariona Riudavets, Cristina Teixidó, Noelia Vilariño, Felipe Couñago, Laura Mezquita. Per Med 2022
0

A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening.
Jrhau Lung, Ming-Szu Hung, Yu-Ching Lin, Yuan Yuan Jiang, Yu-Hung Fang, Ming-Shian Lu, Ching-Chuan Hsieh, Chia-Siu Wang, Feng-Che Kuan, Chang-Hsien Lu,[...]. Sci Rep 2020
2